FDA Approved: SODIUM PHENYLACETATE AND SODIUM BENZOATE — Supplemental Application (MAIA PHARMACEUTICALS, INC)

View source ↗

Summary

FDA approved a supplemental application for sodium phenylacetate and sodium benzoate from Maia Pharmaceuticals, indicating approval of an expanded or continued …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperammonemia
• Urea Cycle Disorder

Drugs mentioned

• Sodium phenylacetate and sodium benzoate (sodium phenylacetate and sodium benzoate)

Snippet

SUPPL AP for SODIUM PHENYLACETATE AND SODIUM BENZOATE (SODIUM PHENYLACETATE AND SODIUM BENZOATE)